Ensysce Biosciences (ENSC) Short Interest Ratio & Short Volume $2.17 -0.06 (-2.47%) As of 02:07 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Ensysce Biosciences Short Interest DataEnsysce Biosciences (ENSC) has a short interest of 144,500 shares. This marks a 7.12% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 923,799 shares to cover all short positions.Current Short Interest144,500 sharesPrevious Short Interest134,900 sharesChange Vs. Previous Month+7.12%Dollar Volume Sold Short$436,390.00Short Interest Ratio0.1 Days to CoverLast Record DateApril 30, 2025Outstanding Shares2,371,000 sharesPercentage of Shares Shorted6.09%Today's Trading Volume44,125 sharesAverage Trading Volume923,799 sharesToday's Volume Vs. Average5% Short Selling Ensysce Biosciences? Sign up to receive the latest short interest report for Ensysce Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENSC Short Interest Over TimeENSC Days to Cover Over TimeENSC Percentage of Float Shorted Over Time Ensysce Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025144,500 shares $436,390.00 +7.1%N/A0.1 $3.02 4/15/2025134,900 shares $302,176.00 +328.3%11.2%0.1 $2.24 3/31/202531,500 shares $80,640.00 +43.2%2.6%0.8 $2.56 3/15/202522,000 shares $85,580.00 -43.3%1.8%0.4 $3.89 2/28/202538,800 shares $209,132.00 -1.0%3.2%0.5 $5.39 2/15/202539,200 shares $227,360.00 +3.7%3.3%0.4 $5.80 1/31/202537,800 shares $259,686.00 -31.2%N/A0.1 $6.87 1/15/202554,900 shares $393,084.00 -35.2%N/A0 $7.16 12/31/202484,700 shares $689,458.00 +85.8%N/A0 $8.14 12/15/202445,600 shares $256,272.00 -60.5%N/A0 $5.62 Get the Latest News and Ratings for ENSC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ensysce Biosciences and its competitors with MarketBeat's FREE daily newsletter. 11/30/2024115,300 shares $854,373.00 -97.6%N/A0.1 $7.41 11/15/20244,850,000 shares $3.25 million -23.6%N/A0.2 $0.67 10/31/20246,350,000 shares $3.66 million +5,514.5%43.4%0.2 $0.58 10/15/2024113,100 shares $19,046.04 -37.2%0.8%0 $0.17 9/30/2024180,200 shares $43,248.00 -11.4%1.6%0.1 $0.24 9/15/2024203,300 shares $66,275.80 -70.5%1.9%0.1 $0.33 8/31/2024689,400 shares $272,313.69 +3,885.0%6.3%0.4 $0.40 8/15/202417,300 shares $6,802.36 -92.7%0.2%0.2 $0.39 7/31/2024235,500 shares $105,975.00 +2.5%3.2%1.7 $0.45 7/15/2024229,800 shares $106,052.70 -16.6%3.2%1.7 $0.46 6/30/2024275,500 shares $139,540.75 +4.0%3.8%2 $0.51 6/15/2024264,800 shares $137,696.00 +37.1%3.6%1.8 $0.52 5/31/2024193,200 shares $111,090.00 +40.0%2.7%1.4 $0.58 5/15/2024138,000 shares $85,435.80 +1,337.5%1.9%0.9 $0.62 4/30/20249,600 shares $5,679.36 +134.2%0.1%0 $0.59 4/15/20244,100 shares $2,785.95 -76.6%0.1%0 $0.68 3/31/202417,500 shares $13,828.50 -69.0%0.6%0 $0.79 3/15/202456,500 shares $44,838.40 -34.4%1.9%0 $0.79 2/29/202486,100 shares $80,279.64 +40.9%3.0%0.1 $0.93 2/15/202461,100 shares $54,379.00 -91.0%2.1%0 $0.89 1/31/2024678,500 shares $1.10 million +175.5%23.3%0.5 $1.62 1/15/2024246,300 shares $337,431.00 +9.1%8.8%0.2 $1.37 12/31/2023225,700 shares $239,242.00 +35.2%8.0%1 $1.06 12/15/2023167,000 shares $185,370.00 +25.3%5.9%0.8 $1.11 11/30/2023133,300 shares $151,962.00 +96.6%4.8%0.9 $1.14 11/15/202367,800 shares $59,806.38 +11.3%2.4%0.9 $0.88 10/31/202360,900 shares $56,094.99 +161.4%2.2%0.8 $0.92 10/15/202323,300 shares $33,552.00 +9.9%0.9%0.3 $1.44 9/30/202321,200 shares $29,256.00 -20.0%0.8%0.4 $1.38 9/15/202326,500 shares $46,375.00 -4.0%1.1%0.1 $1.75Banks aren’t ready for this altcoin—are you? (Ad)While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.Click here to access the full report now. 8/31/202327,600 shares $51,060.00 -2.1%1.1%0.1 $1.85 8/15/202328,200 shares $54,990.00 -36.8%1.0%0.1 $1.95 7/31/202344,600 shares $89,646.00 +81.3%1.9%0.1 $2.01 7/15/202324,600 shares $48,216.00 +24.9%1.4%0 $1.96 6/30/202319,700 shares $36,051.00 -2.5%2.4%0 $1.83 6/15/202320,200 shares $47,470.00 +6.3%2.5%0 $2.35 5/31/202319,000 shares $45,030.00 -83.3%2.3%0 $2.37 5/15/2023113,600 shares $349,888.00 +43.8%11.0%0.2 $3.08 4/30/202379,000 shares $296,250.00 +62.2%6.3%0.1 $3.75 4/15/202348,700 shares $194,366.57 +5.9%3.9%0.2 $3.99 3/31/202346,000 shares $2.68 million -92.1%6.9%0.2 $58.32 3/15/2023580,700 shares $351,904.20 +194.3%17.3%0.3 $0.61 2/28/2023197,300 shares $96,479.70 -28.3%5.7%0.1 $0.49 2/15/2023275,200 shares $167,872.00 -47.6%7.2%0.1 $0.61 1/31/2023525,000 shares $367,500.00 +631.2%9.9%0.2 $0.70 1/15/202371,800 shares $55,321.90 -9.9%1.6%0 $0.77 12/30/202279,700 shares $59,775.00 -44.4%1.7%0.1 $0.75 12/15/2022143,400 shares $131,340.06 -54.6%7.1%0.1 $0.92 11/30/2022315,700 shares $915,530.00 +128.9%17.3%0.3 $2.90 11/15/2022137,900 shares $297,864.00 -8.1%7.5%0.2 $2.16 10/31/2022150,000 shares $484,500.00 -78.5%10.1%0.8 $3.23 10/15/2022698,700 shares $144,630.90 -39.8%3.2%0.5 $0.21 9/30/20221,160,000 shares $249,400.00 -27.5%5.3%1.1 $0.22 9/15/20221,600,000 shares $551,840.00 +134.6%7.4%1 $0.34 8/31/2022681,900 shares $288,034.56 -5.0%3.3%0.5 $0.42 8/15/2022717,500 shares $350,211.75 +30.6%3.5%0.6 $0.49 7/31/2022549,200 shares $282,783.08 -12.1%2.9%0.5 $0.51 7/15/2022624,900 shares $365,628.99 +20.0%3.3%0.5 $0.59 6/30/2022520,600 shares $452,089.04 +45.0%2.9%0.4 $0.87 6/15/2022359,100 shares $169,136.10 +52.9%2.0%0.4 $0.47 5/31/2022234,800 shares $131,652.36 +94.7%1.5%0.2 $0.56 5/15/2022120,600 shares $81,007.02 -83.4%0.9%0.1 $0.67 4/30/2022724,300 shares $796,730.00 +65.0%7.6%0.9 $1.10 4/15/2022439,000 shares $469,730.00 +41.5%4.6%0.6 $1.07 3/31/2022310,200 shares $353,628.00 +139.7%4.0%0.3 $1.14 3/15/2022129,400 shares $139,752.00 -64.0%1.7%0.1 $1.08 2/28/2022359,300 shares $402,416.00 +154.5%4.7%0.1 $1.12 2/15/2022141,200 shares $211,800.00 -59.6%1.8%0 $1.50 1/31/2022349,700 shares $608,478.00 +229.9%4.5%0 $1.74 1/15/2022106,000 shares $347,680.00 -86.8%N/A0 $3.28 12/31/2021801,600 shares $3.77 million -7.7%10.4%0.1 $4.70 12/15/2021868,100 shares $3.57 million +702.3%11.2%0.1 $4.11 11/30/2021108,200 shares $170,956.00 +18.1%1.4%0 $1.58 11/15/202191,600 shares $196,024.00 -58.3%1.2%0.1 $2.14 10/29/2021219,900 shares $483,780.00 +140.3%2.8%0.2 $2.20 10/15/202191,500 shares $216,855.00 -38.8%1.2%0 $2.37 9/30/2021149,400 shares $452,682.00 +280.2%1.6%0.1 $3.03 9/15/202139,300 shares $120,651.00 -20.1%0.4%0 $3.07 8/31/202149,200 shares $155,472.00 +59.7%0.5%0 $3.16 8/13/202130,800 shares $101,024.00 No Change0.3%0 $3.28Trump’s Bitcoin Reserve is No Accident… (Ad)For the first time in history, we have a president who understands crypto's potential to bypass the banking system entirely. And Wall Street's biggest players know it. I've created a blueprint revealing how everyday investors can turn this historic shift into potentially life-changing wealth. Like the 75,000 new millionaires created in the last bull run— only this time with institutional backing.Click Here to Check Out the Crypto Bull Run Millionaire Blueprint ENSC Short Interest - Frequently Asked Questions What is Ensysce Biosciences' current short interest? Short interest is the volume of Ensysce Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 144,500 shares of ENSC short. Learn More on Ensysce Biosciences' current short interest. Is Ensysce Biosciences' short interest increasing or decreasing? Ensysce Biosciences saw a increase in short interest in April. As of April 30th, there was short interest totaling 144,500 shares, an increase of 7.1% from the previous total of 134,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Ensysce Biosciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Ensysce Biosciences: Ovid Therapeutics Inc. (2.37%), ImmunoPrecise Antibodies Ltd. (1.42%), MIRA Pharmaceuticals, Inc. (7.16%), Cognition Therapeutics, Inc. (1.82%), Q32 Bio Inc. (12.54%), Natural Alternatives International, Inc. (0.14%), X4 Pharmaceuticals, Inc. (7.59%), Lisata Therapeutics, Inc. (0.39%), Passage Bio, Inc. (3.42%), VYNE Therapeutics Inc. (1.57%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Ensysce Biosciences stock? Short selling ENSC is an investing strategy that aims to generate trading profit from Ensysce Biosciences as its price is falling. ENSC shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ensysce Biosciences? A short squeeze for Ensysce Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENSC, which in turn drives the price of the stock up even further. How often is Ensysce Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENSC, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Ovid Therapeutics Short Interest ImmunoPrecise Antibodies Short Interest MIRA Pharmaceuticals Short Interest Cognition Therapeutics Short Interest Q32 Bio Short Interest Natural Alternatives International Short Interest X4 Pharmaceuticals Short Interest Lisata Therapeutics Short Interest Passage Bio Short Interest VYNE Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ENSC) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ensysce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ensysce Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
